We are live on ! Find out more
RXST icon

RxSight

214 hedge funds and large institutions have $1.68B invested in RxSight in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 65 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,355% more call options, than puts

Call options by funds: $23.1M | Put options by funds: $1.59M

37% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 65

1.01% more ownership

Funds ownership: 84.53%85.54% (+1%)

6% less funds holding

Funds holding: 228214 (-14)

15% less capital invested

Capital invested by funds: $1.98B → $1.68B (-$305M)

29% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 45

71% less funds holding in top 10

Funds holding in top 10: 72 (-5)

Holders
214
Holders Change
-14
Holders Change %
-6.14%
% of All Funds
3.07%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.03%
New
32
Increased
89
Reduced
65
Closed
45
Calls
$23.1M
Puts
$1.59M
Net Calls
+$21.6M
Net Calls Change
+$18.1M
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$194M +$11.4M +222,000 +6%
BlackRock
2
BlackRock
New York
$138M +$19.8M +386,844 +16%
Vanguard Group
3
Vanguard Group
Pennsylvania
$113M +$14.3M +279,146 +14%
Bank of America
4
Bank of America
North Carolina
$86.3M +$50.8M +990,883 +131%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$59.4M -$2.67M -52,078 -4%
Artisan Partners
6
Artisan Partners
Wisconsin
$57.8M -$8.39M -163,769 -12%
Lord, Abbett & Co
7
Lord, Abbett & Co
New Jersey
$51.9M -$35.1M -685,463 -40%
Invesco
8
Invesco
Georgia
$48.8M -$3.41M -66,586 -6%
State Street
9
State Street
Massachusetts
$40.4M +$3.19M +62,349 +8%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$40.4M +$6.29M +122,775 +18%
DSCM
11
Divisadero Street Capital Management
Florida
$38.2M +$35M +683,640 +760%
SPPAM
12
Summit Partners Public Asset Management
Massachusetts
$34M -$6.46M -126,122 -15%
Deutsche Bank
13
Deutsche Bank
Germany
$32M -$7.78M -151,767 -19%
GGHC
14
Gilder Gagnon Howe & Co
New York
$29M -$970K -18,939 -3%
NCGI
15
Next Century Growth Investors
Minnesota
$28.5M +$2.47M +48,157 +9%
Millennium Management
16
Millennium Management
New York
$28M +$19.4M +378,882 +201%
BCM
17
Brown Capital Management
Maryland
$26.8M +$27.8M +542,437 New
Morgan Stanley
18
Morgan Stanley
New York
$24.1M -$32.3M -630,358 -56%
NSGL
19
No Street GP LP
California
$23.5M +$6.4M +125,000 +36%
DCM
20
Driehaus Capital Management
Illinois
$23.3M -$12M -233,813 -33%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$22.1M +$19.7M +384,041 +610%
Baillie Gifford & Co
22
Baillie Gifford & Co
United Kingdom
$20.7M +$3.11M +60,789 +17%
ACM
23
Atika Capital Management
New York
$20.3M +$410K +8,000 +2%
Northern Trust
24
Northern Trust
Illinois
$18.6M +$3.32M +64,800 +21%
TAM
25
Telemark Asset Management
Massachusetts
$14.9M

RXST Hedge Fund Activity: Q3 2024 in Review

214 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q3 2024, worth a combined $1.68B — down 15% from $1.98B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of RXST and 32 opened new positions — a net loss of 13 holders — while 65 trimmed existing stakes and 89 added.

The largest buyer was Bank of America, adding an estimated $50.8M. The largest seller was Lord, Abbett & Co, cutting an estimated $35.1M.

  • 214 institutional investors held RxSight (RXST) as of Q3 2024, down from 228 in Q2 2024.
  • Funds reported $1.68B of RxSight stock for Q3 2024, down 15% quarter-over-quarter.
  • 32 funds opened new RxSight positions in Q3 2024 and 45 closed out, a net change of -13 holders.
  • The largest RxSight buyer in Q3 2024 was Bank of America, an estimated $50.8M added.
  • The largest RxSight seller in Q3 2024 was Lord, Abbett & Co, an estimated $35.1M sold.

Based on aggregated 13F filings for Q3 2024.